Homoeopathic drug proving: Randomized double blind placebo controlled trial for drug code 127

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Healthy individuals with no apparent disease and normal routine laboratory parameters during screening
•2. Healthy individuals identified as fit for proving by experts
•3. Intelligent enough to record carefully the facts, subjective and objective symptoms generated by the IPS during proving.
•4. Able to be informed of the nature of the study and willing to give written informed consent.

•1. Any disease or condition which might compromise the hematopoietic, renal, endocrine, pulmonary, central nervous system, cardiovascular, immunological, dermatological, gastro-intestinal or any other body system
•2. Persons with colour blindness.
•3. Persons who have undergone surgery in last two months.
•4. Planned medical / dental treatment during the proving period including herbal or dietary supplements, procedures, or medications that are likely to interfere with, or substantially alter, responsiveness to the proving substance.
•5. Volunteers on regular medication (allopathic, ayurvedic, homoeopathic, naturopathic, unani, etc.) for any acute or chronic disease.
•6. Participant must not be on any homoeopathic remedy in the preceding one month and have had no significant change in health status in last one month.
•7. Emotionally disturbed, hysterical or anxious persons.
•8. Persons having known history of allergies, food hypersensitivity, etc.
•9. Women during pregnancy, puerperium and while breast-feeding and women who have undergone hysterectomy.
•10. Smokers who smoke more than 10 cigarettes. per day
•11. Recent history of alcoholism / drug addictions or unlikely to refrain from excessive alcohol consumption / drug intake during the study period.
•12. Participation in another clinical or proving trial during the last 6 months.

发起方

Central Council for Research in Homoeopathy